Through this paper, we have attempted to model the demand for di¤er-ent classes of antibiotics used for respiratory infections in outpatient care in Switzerland using a spatial version of the linear approximate Almost Ideal Demand System (AIDS) model. This model takes spatial dependency into account by means of spatial lags of antibiotic budget shares. We control for the health status of patients and the potential harmful e¤ects of antibiotic use in terms of bacterial resistance. Elasticities to socioeconomic determinants of consumption and own-and cross-price elasticities between di¤erent groups of antibiotic have salso been computed in this paper. Signi…cant cross-price elasticities are found between newer or more expensive generations and older or less expensive generations of antibiotics.
Introduction
Antibiotics di¤er from other pharmaceutical products in several ways (Ellison and Hellerstein, 1999) . They are generally prescribed by doctors because of their pharmacological characteristics. Consequently, the patients'preferences for speci…c therapeutic components may be of little relevance. At the same time, aspects such as the price may play an important role if the consumer was to bear a substantial share of the cost of drugs directly.
In primary care, doctors may face a …rst trade-o¤ between prescribing and delaying an antibiotic therapy because of uncertainty of the nature of a patient's infection (viral or bacterial) . Although antibiotic therapy is not e¤ective against common viral infections, expected cost savings (in terms of time and troubles) in the case of bacterial infections may overcome the expected social loss from bacterial resistance.
From the economic point of view, bacterial resistance accounts for relevant external e¤ects. First, several antibiotic therapies might be prescribed before …nding the e¤ective one, which leads to income loss or possibly premature deaths. Second, the reduced e¤ectiveness of drugs increases social costs to produce new generations of pharmaceutical components.
A second trade-o¤ is observed between prescribing broad spectrum and narrow spectrum antibiotics. Although the intensive use of broad spectrum components, which are generally more expensive, reduces uncertainty in the outcome of the treatment, this may generate higher levels of bacterial resistance. It has been argued that the persistent use of one type of antibiotics may be sub-optimal for the society.
Literature suggests that the negative externality of resistance can be reduced by changing the type of antibiotic used (Ellison and Hellerstein 1999; Laxminarayan and Weitzman, 2002; Rowthorn and Brown, 2003) , since the same type of bacteria may be susceptible to more than one antibiotic component. 1 1 Increasing rates of Streptococcus pneumoniae strains resistant to penicillin has led to the use of macrolides. However, the clinical e¤ectiveness of the latter category has also begun to decrease (Alvarez-Elcoros and Enzler, 1999) . The analysis by Ednie et al. (1996) suggests that in areas where penicillin-resistant strains are common, the empirical antibiotherapy using macrolides should Regional heterogeneity in the mix of antibiotics used has been recently observed within the countries (Filippini et al., 2006; Kern et al., 2006) . This may indicate that some antibiotic components are preferred by local physicians and patients, which raises the issue of optimal use at the local level. The rise of resistant organisms in a particular region can force physicians to face constraints of e¤ectiveness when substituting existing types of antibiotics with newer and more e¤ective ones. This study focuses on factors a¤ecting the local mix of main antibiotics categories in Switzerland, in particular the e¤ect of prices. The demand for speci…c antibiotic groups has been investigated in studies by Ellison et al. (1997) and Chaudhuri et al. (2003) . The focus is on the structure of the demand for two segments of the market: cephalosporins and quinolones. Demand is modelled in two stages. Firstly a substance is singled out from among a set of substances; then, a brand/generic version of the product is chosen. This approach is suitable for the analysis of speci…c categories of antibiotics since the substances constitute close therapeutic substitutes and may be similar in terms of the impact of bacterial resistance. The model relies on the hypothesis that physician and patient decisions within a given antibiotic category do not depend on the availability of alternative categories but are based on the speci…c names of substances. We argue, however, that this scenario may not re ‡ect the patient's and doctor's view correctly. Indeed, doctors and patients tend to be concerned with the e¤ectiveness of broad categories of antibiotics, each including a set of active ingredients with similar characteristics and, for this reason, likely to be di¤erently a¤ected by bacterial resistance. Individuals may then choose from among a limited set of antibiotic types clustered according to common practice and shared beliefs regarding their e¤ectiveness. then be changed.This paper intends to investigate the structure of the demand for antibiotics used for respiratory infections by modelling the decision process of rational patients. 3 We are interested in the price and income sensibility of di¤erent antibiotic categories.
Understanding the determinants of antibiotic treatment practices is necessary to reduce antibiotic misuse and the cost of bacterial resistance. Our …ndings may drive more e¤ective policies to improve the e¢ cient use of the antibiotics in the community. It has been assessed that the expected bene…ts of policy interventions aimed at reducing the misuse of antibiotics in Switzerland is around e6:8 M per year (Filippini et al., 2009) . Appropriate incentives a¤ecting antibiotic consumption and, consequently, levels of bacterial resistance can be designed by policy makers by looking at the price and income sensibility of di¤erent antibiotic groups in our model. Since the large use of broad spectrum antibiotics and/or the persistent use of one type of antibiotics may exacerbate the threat of bacterial resistance, information on price sensibility may be useful. For instance, when implementing policies based upon a tax/subsidy mechanism in addition to information campaigns targeted at consumers and health care providers.
Similar to Ellison et al. (1997) and Chaudhuri et al. (2003) , we model antibiotic demand as a multistage budgeting problem but with a wider set of substances, those that can be prescribed for common respiratory infections in outpatient care.
Outpatient antibiotics are then aggregated in four groups according to what are plausible alternatives in the treatment of respiratory infections (classic penicillins, penicillins amoxi/clav plus 1st and 2nd generations of cephalosporins, 3rd generation of cephalosporins and quinolones, macrolides).
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We analyse the allocation of antibiotic expenditure across antibiotic groups us- 3 We are aware that patients take decisions about antibiotic use under doctor's advice. However, as suggested by several studies, e.g. Cockburn and Pit (1997) , physicians'decisions are in ‡uenced by patient's preferences and we can plausibly assume that the …nal decision about consumption is made by the patient. 4 Most of the antibiotics used in outpatient care are for the treatment of respiratory infections (Blasi et al., 2006; Gonzalves et al., 2001) . We focus on this category and exclude antibiotics that are used for other types of infections. Hence, our categories include all plausible therapeutic substitutes.
ing the Almost Ideal Demand System (AIDS) speci…cation proposed by Deaton and Muellbauer (1980) . The AIDS model is commonly used to estimate price and income elasticities of the demand for goods when expenditure share data are available. 5 We compute own-and cross-price elasticities between old and new generations of antibiotics and between antibiotics that are di¤erently a¤ected by bacterial resistance using data from small geographic areas in Switzerland. We also estimate conditional expenditure elasticities and marginal expenditure shares for each group of antibiotics. The AIDS model is estimated using a relatively new econometric approach that also considers the problem of spatial autocorrelation.
The structure of the article is as follows. Section 2 sketches the application of the linear approximate AIDS model to the demand of antibiotics and discusses some testable hypothesis. Section 3 presents the data and summarizes the variables used in the model. Section 4 gives some analyses and results. And section 5 concludes the paper.
The model
To sketch the demand for antibiotics in outpatient care we build on the AIDS model and extend the approach to include spatial aspects of consumption. We hypothesize that the individual utility derived from the use of antibiotics is weakly separable from quantities of all other types of goods consumed. Consequently, consumers follow a multistage process to allocate their budget to antibacterial products. In the …rst stage, the total spending is allocated to broad categories of goods such as health care versus other types of goods or services. The health care spending is then separated in subgroups such as pharmaceuticals, diagnostic tests and inpatient care. Given the nature of the infection, the budget share for pharmaceuticals is 5 Ma and al. (2004) estimated the share equations of animal product consumption for Chinese households. Combining the AIDS model and the two-stage Heckman procedure, Lazaridis (2004) focused on the factors a¤ecting the demand for di¤erent types of oils and fats in Greece. Boetel and Liu (2003) estimated a meat demand system and investigated the e¤ect of food information on the meat shares consumed.
assigned to antibiotics and other types of drugs. Finally, the choice is between di¤erent categories of antibiotics according to their therapeutic attributes, the risks of bacterial resistance, and the cost of treatment.
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The individual expenditure function derived from the consumer theory is aggregated across individuals to obtain the antibiotic expenditure in the local market area.
7 Muellbauer (1975 Muellbauer ( , 1976 showed that exact aggregation is possible within a speci…c family of preferences. These preferences are known as the price independent generalized logarithmic (PIGLOG) class of preferences. The PIGLOG class can be denoted by the following expenditure function, which is the minimum expenditure necessary to achieve a certain level of utility at any given price
where u is the level of utility, a(p) and b(p) represent functions of a price vector p.
Following Deaton and Muellbauer (1980) we assume
and
where 0 ; i ; 0 ; i and ij are constants, and i and j are indexes representing different antibiotic categories. 6 The Swiss National Research Programme on Antibiotic Resistance (NPR 49) reports that information about the risk of bacterial resistance reach consumers mainly through the doctor and information campaigns, since the other kind of information like newspapers are generally inaccurate. Doctors are regularly informed by regional (cantonal) health authorities and through their own experience of non-e¤ective treatments on their patients. Lea ‡ets are few and also not widely distributed, although some cantonal hospitals deliver guidelines to practitioners in the area. Consumers are generally aware that bacterial resistance a¤ecting some types of antibiotics may be harmful although direct to consumers information is not satisfactory. Patients trust their doctors for a correct understanding of the resistance problem.
7 Aggregation theory provides the necessary conditions under which the aggregate demand, i.e. the representation of market demand, can be treated as if it was the outcome of the decisions of a rational representative consumer. See Muellbauer (1975) and Cornes (1992) for a general discussion.
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The following restrictions are implied by (5) and (8)
8 Demand functions in budget share form are derived from a natural logarithmic di¤erentiation of the expenditure function with respect to prices. 9 Total expenditure x is equal to c(u; p) for a utility maximising consumer. Hence, c(u; p) can be inverted to give u(p; x), the indirect utility function. 10 We de…ne x = P i p i q i as the total expenditure on antibiotics for respiratory infections in outpatient care, where p i and q i represent the price and the quantity for the i th group of antibiotics by the representative consumer.
Provided that Eqs. (5), (8) and (9) hold true, the equation (6) de…nes a system of demand functions. These are homogeneous of degree zero in prices and total expenditure and satisfy the Slutsky symmetry. The total expenditure is then given by P w i = 1.
The interpretation of the demand share summarized by Eq. (6) is straightforward. Without any change in relative prices and expenditures, i.e. the second and the third terms of the right-hand side of the equation, the budget shares of di¤erent groups of antibiotics are constant. Changes in relative prices a¤ect the demand share through the terms ij . These capture the e¤ect on the i th budget share from a 1% increase in the price of the j th category of goods, with x=P held constant.
Changes in real expenditure are taken into account by the parameter i , which is assumed equal to zero.
The share equation also underlines some basic properties of the demand function.
Other things being equal, the expenditure share of each group of commodities is inversely associated with its own price and is positively related to the price of other goods. The expected sign of ii is then negative. On the other side, ij should exhibit a positive sign for any i 6 = j if goods are close substitutes.
Spatial dependency and other determinants
The demand for antibiotics may also be a¤ected by variables other than price that account for expenditure shifts. For instance, the incidence of infections may imply seasonal trends in the per capita consumption. The socioeconomic characteristics of a population and other aspects of health care supply may also a¤ect antibiotic use.
These aspects may be of little relevance in the demand share of di¤erent classes of antibiotics, unless they shape preferences for speci…c antibiotic categories.
It has been suggested that the patients' age signi…cantly a¤ects the route of administration of antibiotics for lower respiratory tract infections (Mazzaglia et al., 1999 ) and the type of antibiotic used (Pendergrast and Marrie, 1999) . Moreover, physicians may have an incentive to prescribe the newer and more expensive antibi-otics, that is ones with a broader spectrum of activity, which apparently reduces risks for patients. Our model can be easily modi…ed to account for expenditure shifts determined by the structure of the population and cultural di¤erences.
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Following Ray (1980) and Pollak and Wales (1992) , we extend our model to include the additional determinants by a log-linear scaling procedure. Cultural di¤erences across regions are taken into account by dummy variables.
From Eq. (6) the AIDS model can then be extended to analyse aggregate data on antibiotic consumption across small geographic areas. Assuming separability in quantities consumed for di¤erent types of goods, we can write the econometric speci…cation as
where ik , i , i , it and i are new parameters. The index i = 1; 2; 3; 4 denotes four groups of antibiotic substances discussed later on in section 3 and summarized in table 1.
From the econometric point of view, the choice of the appropriate method for the estimation of Eq. (10) should consider the possibility of spatial autocorrelation in antibiotic consumption. We found evidence of spatial autocorrelation using the Moran's I test. We then modi…ed the extended AIDS model to take spatial aspects into account. To our knowledge, the economic literature lacks extended AIDS models with spatial e¤ects and the approach has not been previously applied to the consumption of drugs. 12 We introduced spatial lags of consumption in the 11 Socioeconomic determinants of outpatient antibiotic use in Switzerland have been investigated in previous studies by Filippini et al. (2006 Filippini et al. ( , 2009 . The authors apply multivariate parametric approaches to the aggregate demand of antibiotics but fail to investigate determinants of di¤erent antibiotic groups.
12 Spatial dependency in AIDS models has been applied, for instance, by Paraguas et al. (2006) to investigate …sh expenditure in the Philippines. The model, however, does not include socioeconomic factors as determinants of consumption. econometric speci…cation following the spatial autoregressive parameter approach proposed by Anselin (2001) . We added spatial lags of consumption, i M w i , by means of the spatial weight matrix M . 13 The consumption of antibiotic group i in one area is assumed to be a¤ected by the level of consumption in neighbouring areas. Indeed, spatially adjacent areas may exhibit similar behaviour in terms of antibiotic utilization due to inherent common spatial in ‡uences.
The econometric speci…cation in Eq. (10) Finally, DT t (t = 1; ::; 3) are time dummies, and the random term u i is normally 13 The modi…ed version of the AIDS model that uses spatial lags is built on the structure of Dynamic Almost Ideal Demand Systems. The way to introduce dynamic elements into the demand system analysis is discussed, for instance, by Gracia et al. (1998) and Shukur (2002) . The spatial lag can be thought of as an "inertia lag" in the sense that consumers slowly adjust their consumption behaviour with the neighbouring areas. Consequently, spatial dependency can be introduced by means of an autoregressive speci…cation in the demand system equations.
14 Indicators of bacterial resistance are de…ned as ratios between the number of non-susceptible bacteria isolates over the number of tested isolates in regional laboratories and reported in regional hospitals guidelines. We built …ve types of indicators: susceptibility of Staphylococcus aureus (SA), susceptibility of Streptococcus pneumoniae (SP), susceptibility of Escherichia coli (EC), susceptibility of Campylobacter jejeuni (CJ) and susceptibility of all types of bacteria (ALL), which is an average of the above indicators. Since each type of bacteria is tested against di¤erent antibiotic substances, we built susceptibility indicators for each antibiotic group by averaging the results of susceptibility tests to main substances in the group. and identically distributed with variance 2 " . The expenditure share function is linearly homogeneous in all the explanatory variables provided that the new parameters satisfy the following condition:
and P is approximated by the Stone's geometric price index
To avoid simultaneity problems, we use the median values of the expenditure shares to calculate the Stone price index. Moreover, to reduce the risk of endogeneity generated by the fact that prices of di¤erent groups of antibiotics are computed using antibiotic shares, we consider lagged values for prices.
Expenditure and price elasticities
Since we are interested in studying the response of the demand for di¤erent antibiotic groups to changes in price and expenditure, we calculate elasticities at the sample mean of expenditure shares. Using Eqs. (10) and (12) we derive the uncompensated (Marshallian) own-price elasticities (" ii ) and cross-price elasticities (" ij ) as
Using the Slutsky equation, we then obtain the expenditure elasticity for the i th antibiotic category given by
A positive value suggests that good i is normal.
15 See Alston et al. (1994) and Chalfant (1987) for details.
The income compensated or net (Hicksian) own-price elasticities ( ii ) and crossprice elasticities ( ij ) are obtained by applying the Slutsky decomposition to Eq.
(15) and using the price index in (12). These can be written as
Consumer theory suggests that compensated own-price elasticities are negative for normal goods. Moreover, if Eqs. (14) and (17) are positive the two groups of antibiotics are cross substitutes, otherwise they are complements.
Using the Slutsky equation once again, it is possible to derive a relationship between the compensated cross-price elasticities and expenditure elasticities: " ij = w j ij w j i , where ij are the partial elasticities of substitution, known also as the Allen elasticities of substitution
The sign of ij determines whether the goods i and j are complements or substitutes.
If ij is positive (negative) the two goods are substitutes (complements).
Data and variables
Our data covers 240 contiguous market areas that represent the entire Swiss territory. The areas exhibit a good degree of internal homogeneity in terms of population density and providers of health care. Aggregate data on outpatient antibiotic sales of di¤erent classes of antibiotics were provided by IHA-IMS Health Market Research.
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The dataset is detailed at product/brand name and data are available quarterly for 16 Data on antibiotic sales derived from transactions between wholesalers and pharmacies and physicians. Clearly, we are aware that the quantity of antibiotics sold and the quantity actually consumed may di¤er. In this study we assume that patient non-compliance with doctor's prescription, if any, is a negligible factor. Finally, the potential mismatch between wholesale records and prescribing data due to seasonal ‡uctuations of retailer's stocks is assumed to have only a limited temporary e¤ect and is likewise ignored.
2002. Since we focus on respiratory infections, we limited our analysis to the antibiotics mainly used in the treatment of these diseases. However, part of these antibiotics can also be used for the treatment of other types of infections like gastrointestinal infections. We aggregated active substances according to the antibiotic class and the generation. Consequently, we kept 66% of the original dataset in terms of sales. We excluded antibiotics with a parenteral route of administration. Four antibiotic groups were identi…ed (classic penicillins, penicillins amoxi/clav plus 1st and 2nd generation of cephalosporins, 3rd generation of cephalosporins and quinolones, as well as macrolides) using the relevant literature on antibiotic treatments and suggestions by experts. These groups are summarized in Table 1 .
[ Penicillins are among the …rst discovered antibiotics and have been largely used against S. pneumoniae pathogens, which are a primary cause of respiratory tract infections (Schito et al., 2000) . In particular, classic penicillins (penicillins V, ampicillin, amoxicillin) are commonly utilized to treat angina from streptococci and only rarely for other types of respiratory infections. The rate of penicillin-resistance S. pneumoniae has substantially increased since the mid-1980s (CDC, 1994 .
Newer penicillins (amoxi/clav) can be combined with some cephalosporins since they belong to the same broad classi…cation (beta-lactams). The spectrum of amoxi/clav and 2nd generation of cephalosporins are very similar. Observed crossresistance between cephalosporins and penicillins may imply that patients infected by penicillin-resistant bacteria are resistant to cephalosporins as well. The 1st generation of cephalosporins is currently of very little use.
The 3rd generation of cephalosporins has a broader activity spectrum compared to the previous generations, which implies that it can be used against a larger variety of bacteria. Consequently, it is suitable for more severe infections. Nevertheless, it is generally used as an alternative to the 2nd generation. Practices may signi…cantly vary across the areas since some doctors are more likely than others to preserve the 3rd generation for more resistant bacteria.
Similarly, quinolones have a large range of antibacterial activity, which includes multidrug resistant strains responsible for respiratory tract infections. Since this category should also be used with caution and better preserved for more severe cases, we considered it in a group together with the 3rd generation of cephalosporins.
When the nature of the infection is uncertain and doctors are quite risk averse, 3rd
generation of cephalosporins and quinolones may be preferred to penicillins and other cephalosporins. [ Table 2 : about here] Table 2 gives summary statistics of expenditure shares and prices for the four groups of antibiotics. Penicillins (amoxi/clav) and early generations of cephalosporins and macrolides represent the largest shares of the expenditure. Note, however, that strong di¤erences are observed across the areas. These categories may account for only 15% of the total expenditure. On the other hand, in some areas they are largely used and may reach a share of more than 70%.
Information on the other variables included in the model (see Table 3 ) are mainly obtained from IHA-IMS . Demographic variables include the share of the population classi…ed in …ve ranges of age. Note, for instance, that individuals under 26 represent less than 1% of the total population in some areas and more than 20% in others.
Similarly, the proportion of people between 60 and 74 largely varies across areas, from 9:5% to almost 25%. French and Italian speaking areas represent 43:7% of all areas and are generally characterized by a more intensive use of antibiotic per capita. We de…ned a dummy variable that takes value equal to 1 if the area has a Latin culture (French and Italian) and 0 otherwise.
[ Table 3 : about here]
The data on health status of patients is based on information on the incidence of respiratory and common gastrointestinal diseases. As indicators we use the incidence of S. pneumoniae infections, which represent the most common airborne bacterial infections among the population. We alto take the incidence of Campylobacter and Salmonella infections, which are a leading cause of gastrointestinal infections. The reason for including data on gastrointestinal infections is that these data are generally more reliable than those for airborne bacterial infections because of availability of information for all regions, larger sample, and reduced risk of bias. 17 Although in most cases a medical treatment is required to recover from these infections, patients, especially children and old people, may be prescribed an antibiotic when symptoms are particularly severe.
Finally, the magnitude of bacterial resistance is calculated for three macro regions. There is a lack of resistance indicators for outpatient antibiotics covering the Swiss territory. A systematic collection of data had not started until recently. However, regional hospital guidelines include a summary of resistance indicators and are generally prepared every two years and are available to general practitioners. and Zurich (east). Since Lugano and Zurich belong to the same region (east), we averaged indicators from these hospitals guidelines to derive a resistance indicator for the east region. Although the information on antibiotic resistance could be broken into smaller areas, we believe that this is one of the …rst attempts to include resistance indicators in econometric models of antibiotic consumption.
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In our regressions we test …ve susceptibility indicators: Staphylococcus aureus, S. pneumoniae, Escherichia coli, Campylobacter jejeuni, and a mix indicator (average of the above indicators). In Table 3 we report the susceptibility of di¤erent antibiotic groups to the S. pneumoniae which is used as an indicator in the basic speci…cation of the model. The reason is that S. pneumonie is more accurately related to respiratory infections than other bacteria and the impact of the combined indicator is not signi…cantly di¤erent. The ranking between antibiotic groups in terms of bacterial susceptibility is not straightforward since some types of bacteria are more likely to be susceptible to speci…c antibiotic substances.
19 18 Local areas in Switzerland are by far smaller than geographical areas usually investigated in many other countries. It is implausible that bacterial resistance varies signi…cantly across such small areas. Health authorities are responsible for larger areas (cantons). Although we distinguish between "regional"and "local"information on bacterial resistance, the latter are neither available nor are there plans to make them available in the near future. Clearly, there may be a margin for improvement since we rely on information available for three macro areas which represent an aggregation of cantons. However, some cantons are indeed very small and may not be able to provide statistically signi…cant data for the surveillance system. For this reason, the sentinel surveillance system collects and publishes resistance data for macro regions.
19 Also for this reason we consider several resistance indicators. However, the estimation results do not di¤er signi…cantly. In particular, estimations with susceptibility of Streptococcus pneumoniae and the average susceptibility to all bacteria exhibit very similar …gures. The main results of the model are also con…rmed without resistance indicators.
Estimation results
The spatial AIDS model de…ned by Eq. (10) is used to investigate the expenditure shares of di¤erent groups of antibiotics. Explanatory variables include the price of antibiotics, population characteristics like age structure and income and cultural aspects, the incidence of community-acquired infections, and seasonal dummies. In addition, the share of di¤erent antibiotic groups can be in ‡uenced by the level of bacterial resistance and antibiotic consumption in adjacent areas.
We estimate the model through the Zellner's Iterative Seemingly Unrelated Regression (SUR) procedure with the software STATA. The set of restrictions leads to a singular residual variance/covariance matrix. Consequently, we drop one share equation from the system. This is the …rst group (classic penicillins) which represents the smallest budget share on average across the four groups. Using the estimated parameters of the share equations of the other three groups and the restrictions applied above, we then obtain the parameters for the dropped group.
The estimation results are reported in Table 4 . Each equation is estimated with 720 observations, since data for 240 areas are quarterly available, and one quarter is excluded to allow for the use of lagged values for prices. The adjusted R 2 suggests that selected variables explain approximately 36%, 40% and 48% of cross-area variations in the use of antibiotics, respectively for group 2 (penicillins amoxi/clav and early generations of cephalosporins), group 3 (3rd generation of cephaloporines and quinolones) and group 4 (macrolides).
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The estimated spatial autoregressive parameter associated with the lag term DID i is signi…cant and positive.
21 20 The adjusted R 2 reported in our estimations are satisfactory considering that the dataset is dominated by cross-sectional variations, hence we are mainly explaining cross-sectional variation in antibiotic consumption. For a general discussion of the interpretation of the R 2 in AIDS models see Verbeek (2008) . 21 The result suggests the evidence of consumption externalities across the areas. Higher consumption of one group of antibiotics in one area is signi…cantly associated with higher consumption of that group in adjacent areas. A plausible explanation for this result lies in the perceptions of doctors and patients of the antibiotic group that is the most appropriate for the treatment of common respiratory infections. Preferences may be a¤ected by practice styles in adjacent areas.
[ Table 4 : about here]
The impact of consumer expenditure on the demand share of group 2 is negligible, and negative for groups 3 and 4. Note, however, that the coe¢ cients are never signi…cant. As detailed in Table 5 below, income elasticities are all positive, which suggests that di¤erent outpatient antibiotic groups are normal goods.
Most price coe¢ cients are signi…cant at less than 1% with few exceptions, but the demand for group 3 and group 4 seems to be positively related to their own prices and negatively related to the price of other groups. Price elasticities will be analysed later on in section 4.1 as we investigate complementary and substitution e¤ects between antibiotic groups.
The impact of demographic variables and cultural aspects on the demand share of all the four antibiotic groups is plausible but coe¢ cients are not highly signi…cant.
The age class 26 59 (POP 3 ) is the baseline category. The proportion of individuals over 74 years of age (POP 5 ) re ‡ects some health considerations. The coe¢ cient is positive and signi…cant at less than 10% for antibiotic group 3, whereas it is negative and signi…cant at less than 1% for antibiotic group 4. This may suggest that elderly people are more exposed to the risk of severe infections in the community as compared to other individuals and these infections imply greater health risks.
Indeed, antibiotics in group 3 (3rd generation of cephalosporins and quinolones) are commonly used for severe cases. The literature on the determinants of health care expenditure indicates that the increasing prevalence of chronic health problems associated with aging may cause an increase in the utilization of health care services (Di Matteo and Di Matteo, 1998; Di Matteo and Grootendorst, 2002) . We argue that the share of antibiotics for more severe infections may increase with the proportion of elderly patients in the community. Our result is also in accordance with …ndings by Mazzaglia et al. (1999) , who suggested that cephalosporins are the antibiotics most frequently prescribed for lower respiratory tract infections in adults, while macrolides are the less prescribed ones.
We did not …nd clear evidence that a higher proportion of children (POP 1 ) negatively a¤ects the share of antibiotic group 1 (penicillins) and positively a¤ects the share of macrolides. According to Otters et al. (2004) , there has been a decrease in the proportion of narrow-spectrum antibiotics prescribed for children between 1987 and 2001 in the Netherlands. By contrast, the proportion of macrolides increased from 8% to 16%. Similarly, Schindler et al. (2004) showed that macrolides were the most frequently prescribed antibiotics (48:1%) for respiratory infections among children aged between 0 and 6 in Germany.
Areas with a French/Italian culture exhibit a signi…cantly lower consumption of macrolides (group 4) and a higher consumption of 3rd generation cephalosporins and quinolones (group 3) compared to areas with a German culture. Similar di¤erences are observed at a larger scale across European countries. France and Italy, for instance, use a relatively larger amount of 3rd generation cephalosporins as compared to other European countries (Coenen et al. 2006 ). The coe¢ cient of the incidence of infections signi…cantly increases with the share of antibiotics in group 2 and negatively a¤ects antibiotics in group 3. The result hypothesizes that epidemiological di¤erences are relevant in explaining variations in the use of di¤erent types of antibiotics in the community. An increase in the spread of community-acquired infections raises the share of narrow-spectrum antibiotics rather than the share of the latest generation of antibiotics more suitable for severe cases.
The study of the impact of bacterial resistance on the utilization of di¤erent antibiotic groups may add some insights to the analysis of epidemiological aspects although the interpretation needs a lot of carefulness. We did not …nd evidences to suggest that the share of di¤erent antibiotic groups is a¤ected by the degree of bacterial susceptibility in the area, except for group 3. There may be some plausible explanations for this result. Since data are available for macro regions through hospital guidelines, information may only partially become available to consumers.
Guidelines may not reach general practitioners and patients e¤ectively. The extent to which information is correctly understood and utilised cannot be assessed. Therefore, the interpretation of the relationship between bacterial resistance and antibiotic demand in the following section could be undermined by this limitation.
Finally, we …nd remarkable seasonal e¤ects on antibiotic shares. The baseline season is represented by the fourth quarter, i.e. the autumn dummy (October, November, December). The consumption of more expensive antibiotics (group 3 and 4) is higher in winter (1st quarter) and lower during the summer (3rd quarter).
This may connote higher risk aversion of doctors and patients in periods when the incidence of infections is higher and severe infections occur more frequently. Accordingly, the patient's willingness to pay for drugs may rise with the perceived risk of infection. By contrast, less expensive antibiotics, such as penicillins and early generations of cephalosporins, are used less often during the …rst quarter and more often in the summer quarter.
Elasticities
Using the estimation results from Table 4 and applying the de…nitions derived in section 2.2, we calculate the own-price, cross-price and expenditure elasticities of the demand for di¤erent antibiotic groups. The …gures are summarized in Table 5 and Table 6 . Some important implications can be straightforwardly derived. ities for di¤erent types of quinolones, ranging from 0:3 to 2:20. Since our expenditure 22 As mentioned above, the demand system is estimated by assuming separability between the consumption of antibiotics and other goods. The implication of this assumption is that the elasticities are partial elasticities, for example they are conditional upon allocation of total expenditure between antibiotics and other goods. elasticities are very close to one, the consumption share of each group of antibiotics remains constant as the amount spent on other groups changes. The evidence then indicates that antibiotics in outpatient care can be denoted as necessities. As income rises, the need for additional consumption of antibiotics is negligible, ceteris paribus. Grootendorst and Levine (2006) showed that pharmaceutical demand elasticities depend on whether patients receive social assistance, or non-eligible patients have private health insurance. Health insurance in Switzerland is mandatory for residents and the same basic contract is o¤ered by competing private insurance companies. [ Table 6 : about here]
Our estimates indicate that the demand for 3rd generation cephalosporins and quinolones (group 3) and the demand for classic penicillins (group 1) are more price elastic than the demand for penicillins amoxi/clav and 1st and 2nd generation cephalosporins (group 2) and the demand for macrolides (group 4). It is worth noticing that the highest own-price elasticities are found for the most expensive antibiotic category (group 3) and the traditional and less frequently used antibiotics (classic penicillins). The rationale may be that doctors and patients are more likely to increase or reduce the consumption of the latest generation of cephalosporins and quinolones when their price changes, since this category of antibiotics is at least partially used to reduce uncertainty on the severity of the infection and the risks of bacterial resistance. On the other hand, they are less likely to leave commonly used antibiotic therapies such as previous generations of cephalosporins, penicillins and macrolides. Classic penicillins represent a traditional antibiotic therapy whose comparative advantage has been substantially undermined by better alternatives.
Consequently, they may be quite sensitive to variations in relative prices.
As expected, the Hicksian own-price elasticities are smaller in magnitude compared to the Marshallian elasticities. This indicates that the pure e¤ect of substitution is only partially compensated by the income e¤ect.
Substitution and complementary relationships among antibiotic groups are captured by the Allen elasticities summarized in Table 6 . Positive values denote that the two groups are substitutes. In our case, narrow spectrum antibiotics such as penicillins amoxi/clav and early generations of cephalosporins (group 2) do not appear to be good substitutes for antibiotics with a larger spectrum such as new cephalosporins and quinolones (group 3). The rationale may be that old generations of cephalosporins are not perceived to be e¤ective against severe infections.
Moreover, newer generations are generally taken into account to overcome speci…c problems of bacterial resistance encountered in the use of previous generations.
When the price of group 1 (classic penicillins) and group 4 (macrolides) increases, doctors may prefer to switch to penicillins amoxi/clav and cephalosporins (group 2) rather than to more e¤ective antibiotics such as newer generations of cephalosporins and quinolones (group 3). Elasticities of substitution between groups 1 and 4 and groups 2 and 3 are positive.
The Allen's elasticity of substitution con…rms that the demand for classic penicillins follows the demand for macrolides when the price of the latter category changes. The result may be associated with a certain degree of persistency in the patient's tastes. For instance, doctors argue that children have a preference for macrolides rather than penicillins. This could imply that an increase in the price of macrolides is likely to induce a higher consumption of cephalosporins or newer antibiotic components, rather than drive the utilization of classic penicillins upward, ceteris paribus.
Conclusion
Antibiotic misuse and the cost of bacterial resistance are major threats to e¢ cient treatment against community-acquired respiratory infections. The demand for antibiotics has been investigated in studies by Ellison et al. (1997) and Chaudhuri et al. (2003) . Their focus is on speci…c market segments where antibiotic substances constitute close therapeutic substitutes and are similar in terms of the impact of bacterial resistance. There are, however, arguments for considering a more extended set of drugs. The major contribution of this study is the investigation of sources of local variations in the use of di¤erent types of antibiotics in the community using an econometric approach that takes into account the problem of spatial autocorrelation.
For this reason, we included a spatial lag on antibiotic consumption in the linear approximate demand system model to investigate antibiotic consumption across small areas. Moreover, we added several socioeconomic determinants of antibiotic use in the model, such as demographic and cultural characteristics of the population and the patients'health status. Therapeutic components are aggregated in four groups suitable to de…ne, to the best of our knowledge, the doctor's and patient's choice set in the treatment of community-acquired respiratory infections in Switzerland.
Estimations are carried out on 2002 quarterly data of de…ned daily doses per 1000 inhabitants (DID) available for 240 small areas.
The results lead us to the conclusion that the highest price demand elasticities are observed for the 3rd generation cephalosporins and quinolones, which are the newer and more expensive antibiotic category; and classic penicillins, which are the most traditional and cheaper category. We found complementary e¤ects between antibiotics with a relatively narrow spectrum (penicillins amoxi/clav and cephalosporins 1st/2nd generations) and antibiotics with a relatively large spectrum (3rd generation cephalosporins and quinolones), and between classic penicillins and macrolides. The demand elasticity suggests a good degree of substitution between the other groups, for instance between penicillins amoxi/clav and cephalosporins 1st/2nd generations (group 2) and macrolides (group 4).
Looking at the impact of population characteristics, we observed that an increasing proportion of elderly people positively a¤ects the proportion of new cephalosporins/quinolones (group 3) and reduces the proportion of macrolides used. The rationale behind this may be that elderly people are more exposed to severe infections and to the risk of bacterial resistance. Italian-and French-speaking regions are associated with a more substantial use of newer and more expensive antibiotics (group 3) and a lower proportion of macrolides (group 4).
Because di¤erent groups of antibiotics are associated with di¤erent degrees of bacterial resistance, variations in the practice of physicians and in the patients'attitudes are probably related to the stance towards the risk of bacterial resistance.
If bacterial resistance is developed for a certain class of antibiotics, no amount of cross elasticity between this class and another class may persuade patients to purchase or doctors to prescribe the ine¤ective class. Our approach makes an attempt to take this aspect into account. Ignoring the possibility of awareness of bacterial resistance by the general public would leave some ambiguities in our model. Our analysis addresses the consumer's willingness to trade o¤ a lower level of bacterial resistance to a relatively higher price, since we tested the impact of available information on bacterial resistance. Some evidence was found for one antibiotic group (new cephalosporins/quinolones) only. This points at possible limitations of our data. Firstly, data on bacterial resistance are available for macro regions only rather than for local areas. Note, however, that relevant information on bacterial resistance in Switzerland is meaningful at regional level. Although variations across smaller areas are plausibly of little relevance and, consequently, not monitored, current indicators are built on a limited number of sources. Secondly, information on bacterial resistance may not be widely disseminated since it derives from guidelines prepared by regional hospitals and are not always delivered to practitioners and consumers. Finally, our resistance indicators may not fully re ‡ect the e¤ectiveness of antibiotic groups that combine di¤erent antibiotic substances. Clearly, we cannot verify whether the dissemination of resistance data is e¤ective and patients are fully aware of the resistance problem even though collected data are reliable and resistance indicators are easy to understand since they are provided in the form of simple ratios.
Despite limitations, the analysis helps to enlighten the impact of determinants of variations in the use of di¤erent types of antibiotics in the community. Our …nd-ings indicates that health care policy makers may improve e¢ ciency in antibiotic use by taking economic incentives into account. One example can be a more e¤ec-tive dissemination of information on prices and the impact of bacterial resistance to physicians and patients. The Swiss Sentinella on antimicrobial resistance relies on a network of laboratories in the country and publishes resistance indicators on the web. The collection of data and the provision to the Sentinella can be eased by the implementation of a national monitoring centre, to be appointed by the federal authority. The information provided could then be used by regional health authorities to prepare lea ‡ets and publish articles in newspapers targeted at the general public and/or general practitioners. Finally, the dissemination of information could be combined with another policy instrument like a regional tax/subsidy system that induces the use of antibiotic categories less a¤ected by resistance problems or antibiotics (generally those with narrow spectrum) that are less likely to contribute to the resistance problem. Table 6 : Allen elasticity of substitution between two groups of antibiotics.
